Arzerra and Joint pain - a phase IV clinical study of FDA data
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Arzerra?
Arzerra has active ingredients of ofatumumab. Currently, eHealthMe is studying from 1,029 Arzerra users.
What is Joint Pain?
Joint pain is found to be associated with 4,860 drugs and 4,988 conditions by eHealthMe. Currently, we are studying 506,133 people who have Joint pain.
Do you take Arzerra and have Joint pain?Check whether Joint pain is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Arzerra side effects by duration, gender and age:
- Arzerra side effects (1,029 reports)
Joint pain treatments and more:
- Joint pain (506,133 reports)
All the drugs that are associated with Joint pain:
All the conditions that are associated with Joint pain:
How the study uses the data?
The study uses data from the FDA. It is based on ofatumumab (the active ingredients of Arzerra) and Arzerra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cefprozil and Pepcid Complete drug interaction - a second ago
- Methotrexate and Tumor Pain - a second ago
- Fenofibrate and Flunisolide drug interaction - 4 seconds ago
- Topiramate and Rinvoq drug interaction - 11 seconds ago
- Entacapone and Muscle Spasms - 12 seconds ago
- Ibrutinib and Respiratory Disorder - 14 seconds ago
- Septra Ds and Drug Withdrawal Syndrome - 19 seconds ago
- Nitroglycerin and Localised Infection - 25 seconds ago
- Hydromorphone Hydrochloride and Nalbuphine drug interaction - 33 seconds ago
- Avodart and Etodolac drug interaction - 43 seconds ago